Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00565500Phase 4Completed
Phase 4, randomised, double-blind trial of celecoxib in osteoarthritis (OA) (3 arms), sponsored by Università degli Studi Gabriele d'Annunzio Chieti e Pescara. Primary endpoint: Serum Thromboxane B2 at 1 week. Started Apr 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00565500.